| Variables . | RV dysfunction (n = 69 patients) . | No RV dysfunction (n = 69 patients) . | P-value . |
|---|---|---|---|
| CABG | 62 (90%) | 63 (91%) | 0.50 |
| Mean number of CABG | 2.5 ± 1.6 | 2.7 ± 1.6 | 0.37 |
| Use of left ITA | 61 (88%) | 63 (91%) | 0.39 |
| Patch closure | 40 (58%) | 36 (52%) | 0.30 |
| mitral valve repair | 25 (36%) | 24 (35%) | 0.50 |
| Postoperative inotropes | 54 (78%) | 40 (60% | 0.01 |
| Postoperative IABP | 22 (32%) | 11 (16%) | 0.03 |
| Postoperative complication | |||
| Low-output syndrome | 8 (12%) | 2 (4%) | 0.01 |
| CVA | 0 (0%) | 1 (2%) | 0.49 |
| Ventricular Arrhythmias | 8 (12%) | 5 (8%) | 0.30 |
| Atrial fibrillation | 14 (20%) | 15 (21%) | 0.55 |
| Acute renal failure | 7 (10%) | 3 (5%) | 0.17 |
| PM implant | 4 (6%) | 1 (2%) | 0.19 |
| Preoperative ACEF score | 2.7 ± 0.9 | 2.5 ± 0.9 | 0.23 |
| 30-day mortality | 10 (14%) | 7 (10%) | 0.18 |
| Long-term mortality | 22 (36%) | 6 (10%) | 0.01 |
| Preoperative TAPSE (1) | 14.0 | 20.0 | 0.01 |
| At discharge TAPSE (2) | 13.5 | 13.9 | 0.87 |
| At follow-up TAPSE (3) | 14.4 | 16.4 | 0.02 |
| P between (1) and (2) | 0.75 | 0.01 | |
| P between (2) and (3) | 0.68 | 0.03 | |
| Variables . | RV dysfunction (n = 69 patients) . | No RV dysfunction (n = 69 patients) . | P-value . |
|---|---|---|---|
| CABG | 62 (90%) | 63 (91%) | 0.50 |
| Mean number of CABG | 2.5 ± 1.6 | 2.7 ± 1.6 | 0.37 |
| Use of left ITA | 61 (88%) | 63 (91%) | 0.39 |
| Patch closure | 40 (58%) | 36 (52%) | 0.30 |
| mitral valve repair | 25 (36%) | 24 (35%) | 0.50 |
| Postoperative inotropes | 54 (78%) | 40 (60% | 0.01 |
| Postoperative IABP | 22 (32%) | 11 (16%) | 0.03 |
| Postoperative complication | |||
| Low-output syndrome | 8 (12%) | 2 (4%) | 0.01 |
| CVA | 0 (0%) | 1 (2%) | 0.49 |
| Ventricular Arrhythmias | 8 (12%) | 5 (8%) | 0.30 |
| Atrial fibrillation | 14 (20%) | 15 (21%) | 0.55 |
| Acute renal failure | 7 (10%) | 3 (5%) | 0.17 |
| PM implant | 4 (6%) | 1 (2%) | 0.19 |
| Preoperative ACEF score | 2.7 ± 0.9 | 2.5 ± 0.9 | 0.23 |
| 30-day mortality | 10 (14%) | 7 (10%) | 0.18 |
| Long-term mortality | 22 (36%) | 6 (10%) | 0.01 |
| Preoperative TAPSE (1) | 14.0 | 20.0 | 0.01 |
| At discharge TAPSE (2) | 13.5 | 13.9 | 0.87 |
| At follow-up TAPSE (3) | 14.4 | 16.4 | 0.02 |
| P between (1) and (2) | 0.75 | 0.01 | |
| P between (2) and (3) | 0.68 | 0.03 | |
Bold values were used to highlight the significant P-value (<0.05).
CVA: cerebrovascular accident; IABP: intra-aortic balloon pump; ITA: internal thoracic artery; TAPSE: tricuspid annular plane systolic excursion; RV: right ventricular; CABG: coronary artery bypass grafting; ACEF: age, creatinine and ejection fraction.
| Variables . | RV dysfunction (n = 69 patients) . | No RV dysfunction (n = 69 patients) . | P-value . |
|---|---|---|---|
| CABG | 62 (90%) | 63 (91%) | 0.50 |
| Mean number of CABG | 2.5 ± 1.6 | 2.7 ± 1.6 | 0.37 |
| Use of left ITA | 61 (88%) | 63 (91%) | 0.39 |
| Patch closure | 40 (58%) | 36 (52%) | 0.30 |
| mitral valve repair | 25 (36%) | 24 (35%) | 0.50 |
| Postoperative inotropes | 54 (78%) | 40 (60% | 0.01 |
| Postoperative IABP | 22 (32%) | 11 (16%) | 0.03 |
| Postoperative complication | |||
| Low-output syndrome | 8 (12%) | 2 (4%) | 0.01 |
| CVA | 0 (0%) | 1 (2%) | 0.49 |
| Ventricular Arrhythmias | 8 (12%) | 5 (8%) | 0.30 |
| Atrial fibrillation | 14 (20%) | 15 (21%) | 0.55 |
| Acute renal failure | 7 (10%) | 3 (5%) | 0.17 |
| PM implant | 4 (6%) | 1 (2%) | 0.19 |
| Preoperative ACEF score | 2.7 ± 0.9 | 2.5 ± 0.9 | 0.23 |
| 30-day mortality | 10 (14%) | 7 (10%) | 0.18 |
| Long-term mortality | 22 (36%) | 6 (10%) | 0.01 |
| Preoperative TAPSE (1) | 14.0 | 20.0 | 0.01 |
| At discharge TAPSE (2) | 13.5 | 13.9 | 0.87 |
| At follow-up TAPSE (3) | 14.4 | 16.4 | 0.02 |
| P between (1) and (2) | 0.75 | 0.01 | |
| P between (2) and (3) | 0.68 | 0.03 | |
| Variables . | RV dysfunction (n = 69 patients) . | No RV dysfunction (n = 69 patients) . | P-value . |
|---|---|---|---|
| CABG | 62 (90%) | 63 (91%) | 0.50 |
| Mean number of CABG | 2.5 ± 1.6 | 2.7 ± 1.6 | 0.37 |
| Use of left ITA | 61 (88%) | 63 (91%) | 0.39 |
| Patch closure | 40 (58%) | 36 (52%) | 0.30 |
| mitral valve repair | 25 (36%) | 24 (35%) | 0.50 |
| Postoperative inotropes | 54 (78%) | 40 (60% | 0.01 |
| Postoperative IABP | 22 (32%) | 11 (16%) | 0.03 |
| Postoperative complication | |||
| Low-output syndrome | 8 (12%) | 2 (4%) | 0.01 |
| CVA | 0 (0%) | 1 (2%) | 0.49 |
| Ventricular Arrhythmias | 8 (12%) | 5 (8%) | 0.30 |
| Atrial fibrillation | 14 (20%) | 15 (21%) | 0.55 |
| Acute renal failure | 7 (10%) | 3 (5%) | 0.17 |
| PM implant | 4 (6%) | 1 (2%) | 0.19 |
| Preoperative ACEF score | 2.7 ± 0.9 | 2.5 ± 0.9 | 0.23 |
| 30-day mortality | 10 (14%) | 7 (10%) | 0.18 |
| Long-term mortality | 22 (36%) | 6 (10%) | 0.01 |
| Preoperative TAPSE (1) | 14.0 | 20.0 | 0.01 |
| At discharge TAPSE (2) | 13.5 | 13.9 | 0.87 |
| At follow-up TAPSE (3) | 14.4 | 16.4 | 0.02 |
| P between (1) and (2) | 0.75 | 0.01 | |
| P between (2) and (3) | 0.68 | 0.03 | |
Bold values were used to highlight the significant P-value (<0.05).
CVA: cerebrovascular accident; IABP: intra-aortic balloon pump; ITA: internal thoracic artery; TAPSE: tricuspid annular plane systolic excursion; RV: right ventricular; CABG: coronary artery bypass grafting; ACEF: age, creatinine and ejection fraction.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
